Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.74 USD | +3.31% | +8.71% | -13.12% |
04-26 | Cytokinetics Appoints Sung Lee as CFO | MT |
04-18 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 1.15B | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : Starts Phase 2 Trial of Combination Therapy for Chronic Hepatitis B